Classical Hematology: A Specialty in Decline?

As workforce shortages persist, this ancient art is undergoing a modern renaissance. Two factors influenced Alfred Ian Lee, MD, PhD, to specialize in classical hematology. The first was joining his father, a pathologist, in viewing...

Online Exclusives

Ropeginterferon alfa-2b-njft Approved for Polycythemia Vera

The U.S. Food and Drug Administration (FDA) has approved ropeginterferon alfa-2b-njft for the treatment of adult patients with polycythemia vera (PV). This decision is based...

Are Hospital Leaders Doing Enough to Address Supply Chain Issues?

A poll by consulting firm Sage Growth Partners on behalf of inventory management platform Syft found that among 100 organizations, 93% have taken action...

News

From the Blood Journals

Idiopathic Multicentric Castleman Disease: Identifying Prevalence and New Treatment Targets

Two recent studies published in Blood Advances explored idiopathic multicentric Castleman disease (iMCD). Researchers led by Sudipto Mukherjee, MD, MPH, of Cleveland Clinic, provided...

Long-Term Hydroxyurea May Improve Cardiac Abnormalities in Young Patients With Sickle...

Long-term hydroxyurea therapy in children with sickle cell disease (SCD) may reverse cardiac remodeling, according to new research findings. Lead study author Arushi Dhar,...

Sponsored Content

Multimedia

Kathi Mooney: Impact of Remote Monitoring on Patients with Cancer During...

Remote monitoring and treatment of cancer and treatment-related symptoms during the COVID-19 pandemic was associated with significant reductions in symptom burden and improvements in...

Ann LaCasce: PET Adapted Therapy Allows Omission of Radiation Therapy in...

Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology’s CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.

Paolo Ghia: Ibrutinib Plus Venetoclax Produces Deep Responses in Patients with...

Here, Paolo Ghia, MD, PhD, of Vita-Salute San Raffaele University in Milan, Italy, discusses recent findings from the phase II CAPTIVATE study evaluating fixed-duration...

Vincent Wagner and Ellen Marcus: Use of the Khorana Score to...

Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.

On Location

HPSCs and Hematopoiesis: From Development to Stem Cell Therapies

As part of this year’s Scientific Program, Gay M. Crooks, MBBS, and Christopher M. Sturgeon,...

The Future of Iron Therapeutics

Therapies for disorders of iron metabolism are rapidly progressing beyond venesection, chelation, and nutritional iron...

Blood and Beyond: Irrigating the Clinical Desert

This year’s Blood and Beyond session will be hosted by Nancy Berliner, MD, Editor-in-Chief of Blood,...

The Hematology Laboratory of the Future

Recent and profound advances in artificial intelligence (AI), data science, and computer vision are having a...

Covering the Full Breadth and Depth of Hematology

Interview with Education Program co-chairs Alison Loren, MD, and Anita Rajasekhar, MD What were your goals...

Are New Clinical Trial Designs Effective?

Among the goals of the ASH Subcommittee on Clinical Trials is to increase accrual to...

Latest Headlines

Advertisement

ASH Directions

ASH Directions

ASH Releases Clinical Practice Guidelines on Stem Cell Transplantation in SCD, Honors Donna S....

NEW! ASH Clinical Practice Guidelines on Stem Cell Transplantation in Sickle Cell Disease The American Society of Hematology (ASH) has published clinical practice guidelines on...
ASH Directions

Key Dates and Safety Measures for the 2021 ASH Annual Meeting, and more

Key Dates and Safety Measures for the 2021 ASH Annual Meeting The 63rd American Society of Hematology (ASH) Annual Meeting and Exposition will take place...

Sign up for our
eNewsletter!

The Society Pages

Remembering Elihu “Eli” Estey, Thomas Waldmann, and more

Remembering Elihu (Eli) Estey (1946 - 2021) Renowned hematologist Elihu (Eli) Estey, MD, died suddenly on October 11, 2021, at the age of 75.After completing...
The Society Pages

NCI Grants $1.8M for Cancer Genome Atlas Research, Sarah Cannon Names Navneet Majhail Physician-in-Chief...

Sarah Cannon Appoints Navneet Majhail as Deputy Physician-in-Chief of Blood Cancers Sarah Cannon Research Institute has named Navneet Majhail, MD, deputy physician-in-chief of blood cancers...
The Society Pages

Remembering Alvin Zipursky, Paul Frenette, and more

Remembering Alvin Zipursky (1930 – 2021) Alvin Zipursky, MD, a leader in the field of pediatric hematology, died on August 10.Dr. Zipursky was professor emeritus...

Classical Hematology: A Specialty in Decline?

As workforce shortages persist, this ancient art is undergoing a modern renaissance. Two factors influenced Alfred Ian Lee, MD, PhD, to specialize in classical hematology....

The Drug Shortages Dilemma

In hematology/oncology, drug shortages typically affect older, less expensive drugs, but when no alternatives are available, clinicians may struggle to provide the best care. It’s...

The Preservation Conversation

Discussions about possible infertility in young patients with cancer should happen early, and often. Chemotherapy, radiation, and hematopoietic cell transplantation (HCT) are essential treatment options...